Cleared Traditional

K875071 - ASPARTATE AMINOTRANSFERASE AST/SGOT

K875071 is the FDA 510(k) clearance for ASPARTATE AMINOTRANSFERASE AST/SGOT by Tech-Co, Inc.. It is a Class 2 Chemistry device (product code CIT) cleared through the Traditional 510(k) pathway after a 71-day FDA review.

K875071 · Tech-Co, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1988
Decision
71d
Days
Class 2
Risk

K875071 is an FDA 510(k) clearance for the ASPARTATE AMINOTRANSFERASE AST/SGOT. Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by Tech-Co, Inc. (Oak Park, US). The FDA issued a Cleared decision on February 18, 1988 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1100 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Tech-Co, Inc. devices

Submission Details

510(k) Number K875071 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 09, 1987
Decision Date February 18, 1988
Days to Decision 71 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 88d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 109
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K875071.
CLINISTAT SGOT (AST) REAGENT TEST
K885156 · Heraeus Kulzer, Inc. · Feb 1989
ASPARTATE AMINOTRANSFERASE TEST ITEM NO. 65654
K884377 · Em Diagnostic Systems, Inc. · Dec 1988
ASPARTATE AMINOTRANSFERASE ASSAY KIT (IFCC)
K880692 · Diagnostic Chemicals, Ltd. (Usa) · May 1988
EASY-TEST ASPARTATE AMINOTRANSFERASE (ASAT) #19010
K874600 · Em Diagnostic Systems, Inc. · Jan 1988
BIOTROL AST/TGO MONOREACTIF
K872829 · Biotrol, USA, Inc. · Aug 1987
ASPARTATE AMINOTRANSFERASE (AST)/(GOT)
K870077 · Catachem, Inc. · Mar 1987